Veterinary Medicines

LIDOCAINA 2%, 20 mg/ml + 0,02 mg/ml, soluzione iniettabile per cani e gatti

Authorised
  • Lidocaine hydrochloride
  • Noradrenaline tartrate
Download as PDF

Product identification

Medicine name:
LIDOCAINA 2%, 20 mg/ml + 0,02 mg/ml, soluzione iniettabile per cani e gatti
Active substance:
  • Lidocaine hydrochloride
  • Noradrenaline tartrate
Target species:
  • Cat
  • Dog
Route of administration:
  • Subcutaneous use
  • Epidural use
  • Top-dressing use

Product details

Active substance and strength:
  • Lidocaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Noradrenaline tartrate
    0.02
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
    • Dog
  • Epidural use
    • Cat
    • Dog
  • Top-dressing use
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Azienda Terapeutica Italiana A.T.I. S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 100452
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 7/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."